Literature DB >> 18835062

Psoriasis: improving adherence to topical therapy.

Steven R Feldman1, Elizabeth J Horn, Rajesh Balkrishnan, Mohammad K Basra, Andrew Y Finlay, Dan McCoy, Alan Menter, Peter C M van de Kerkhof.   

Abstract

Topical therapy has an important role in psoriasis treatment. It is efficacious and has a favorable safety profile as demonstrated in clinical trials. However, poor treatment outcomes from topical therapy regimens likely result from poor adherence and ineffective use of the medication. The International Psoriasis Council Topical Therapy Working Group has developed a new model to describe the complex interactions among patient, disease, and treatment characteristics, adherence behavior, and treatment outcomes. Recommendations are provided that may assist the health care provider in encouraging adherent behavior in their patients. By understanding and manipulating the factors that affect treatment adherence, improvement in adherence is possible and hence better control and outcomes in the topical treatment of psoriasis are likely.

Entities:  

Mesh:

Year:  2008        PMID: 18835062     DOI: 10.1016/j.jaad.2008.08.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

Review 1.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

2.  Efficacy, Safety, and Out-of-pocket Costs are the Most Important Factors to Patients in Choosing a Psoriasis Therapy.

Authors:  Aaron M Secrest; Ali Matinrazm; Laura K Ferris
Journal:  J Clin Aesthet Dermatol       Date:  2014-12

3.  Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Giacomo Bruno; Giampiero Girolomoni; Gino Antonio Vena
Journal:  Clinicoecon Outcomes Res       Date:  2012-09-13

4.  Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis.

Authors:  Eliana Krulig; Kenneth B Gordon
Journal:  Core Evid       Date:  2010-07-27

5.  A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE).

Authors:  K A Papp; K Barber; R Bissonnette; M Bourcier; C W Lynde; Y Poulin; J Shelton; J Toole; A Vieira; M Poulin-Costello
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-07-01       Impact factor: 6.166

6.  Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ).

Authors:  Ina Zschocke; Ulrich Mrowietz; Annett Lotzin; Eleni Karakasili; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2014-02-08       Impact factor: 3.017

7.  Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients.

Authors:  Marianne Lind; Kim Troensegaard Nielsen; Line Hollesen Schefe; Kasper Nørremark; André Huss Eriksson; Hanne Norsgaard; Brian Thoning Pedersen; Karsten Petersson
Journal:  Dermatol Ther (Heidelb)       Date:  2016-06-29

8.  Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).

Authors:  Sandra Swimberghe; Pierre-Dominique Ghislain; Evis Daci; Katrien Allewaert; Kris Denhaerynck; Christine Hermans; Christy Pacheco; Stefaan Vancayzeele; Karen Macdonald; Ivo Abraham
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

9.  Non-adherence to topical treatments for actinic keratosis.

Authors:  Bav Shergill; Simon Zokaie; Alison J Carr
Journal:  Patient Prefer Adherence       Date:  2013-12-17       Impact factor: 2.711

10.  Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).

Authors:  Kristian Reich; Ulrich Mrowietz; Eleni Karakasili; Ina Zschocke
Journal:  Arch Dermatol Res       Date:  2014-06-04       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.